Results 151 to 160 of about 349,010 (252)
Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma
American Journal of Hematology, Volume 101, Issue 10, Page 2652-2653, October 2026.
Léa Ousset +2 more
wiley +1 more source
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg +9 more
wiley +1 more source
Influencing factors and diagnostic yield of second-look ultrasound-guided pleural biopsy based on CT characteristics: a real-world study. [PDF]
He JQ +6 more
europepmc +1 more source
Diagnosis of Pleural Fluid Effusions by Cell Block and Pleural Biopsy - A Comparative Study.
Rani SSS +3 more
europepmc +1 more source
ABSTRACT Cytomegalovirus (CMV) is a prevalent herpesvirus that remains typically asymptomatic in immunocompetent individuals but can cause severe, potentially life‐threatening disease in immunocompromised patients. This study assessed the impact of CMV‐associated lower respiratory tract infections (LRTIs), diagnosed by polymerase chain reaction (PCR ...
Theodora Zouvani +10 more
wiley +1 more source
Endoscopic ultrasound-guided pleural biopsy in the hands of the pulmonologist. [PDF]
Bibi R +5 more
europepmc +1 more source
Background: As the accumulation of fluid in the pleural cavity is a common finding in patients with cancer, its diagnosis deserves careful consideration.
MalekMohammad, M., Solooki, M.
core
Clinical and Molecular Features of BAP1‐Mutated Meningiomas: Case Series
ABSTRACT BRCA1‐associated protein 1 (BAP1)‐deficient meningiomas represent a clinically and molecularly distinct subgroup with variable histology and aggressive behavior that may not be fully captured by current grading criteria. The clinical spectrum of BAP1 alterations in meningiomas, including both somatic and germline contexts, remains incompletely
Ivan Pradilla +7 more
wiley +1 more source
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer
Mesothelin overexpression activate important pathways like nuclear factor k‐light‐chain‐enhancer of activated B cells (NF‐κB) and interleukin‐6 (IL‐6). This in turn causes numerous cancers, such as pancreatic and ovarian cancers. MSLN‐targeting immunotherapies, like monoclonal antibodies, have shown efficacy.
Manoj Kumar Gupta +2 more
wiley +1 more source

